{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-22-000003","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2022-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.204906+00:00","generated_at":"2026-06-27T18:03:09.800730+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Stryker realigns into MedSurg/Neurotechnology and Orthopaedics/Spine segments effective Dec 31, 2021","bullets":["Segments reflect new internal structure after COO transition; Pierce leads MedSurg/Neuro, Stiles leads Ortho/Spine.","FY 2021 recast sales: MedSurg/Neuro $8,345M, Ortho/Spine $6,006M, total $14,351M.","Q4 2021 recast sales: MedSurg/Neuro $2,429M, Ortho/Spine $1,833M, total $4,262M.","Exhibit 99.1 provides recast historical sales for 2019, 2020, and full-year 2021.","Change aligns with previously announced management responsibilities transition."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-22-000003","json":"https://secwatch.observer/filing/0000310764-22-000003.json","markdown":"https://secwatch.observer/filing/0000310764-22-000003.md","text":"https://secwatch.observer/filing/0000310764-22-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076422000003/0000310764-22-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076422000003/syk-20220114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T18:03:09.800730+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}